Randomized, single-dose, four way crossover trial of dimethyl fumarate [FP187] in healthy volunteers

Trial Profile

Randomized, single-dose, four way crossover trial of dimethyl fumarate [FP187] in healthy volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 16 Sep 2015

At a glance

  • Drugs Dimethyl fumarate (Primary) ; Calcium monoethyl fumarate/dimethyl fumarate/magnesium monoethyl fumarate/zinc monoethyl fumarate
  • Indications Multiple sclerosis; Plaque psoriasis; Psoriatic arthritis
  • Focus Pharmacokinetics
  • Sponsors Forward Pharma
  • Most Recent Events

    • 16 Sep 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top